MEPs back joint assessment of medicines

European Parliament's aim is to boosts cooperation in health technology assessment

Photo: European Parliament

Health Committee MEPs backed plans to boost joint assessment of medicines. The legislative report was adopted with 40 votes to 3, with 2 abstentions. It will be put to a vote by the full House during its 1-4 October plenary session in Strasbourg. The new law aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing and reimbursement. 

MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones being the lack of new treatments for certain diseases and the high price of medicines, which in many cases do not have added therapeutic value.

Health professionals, patients and institutions need to know whether or not a new medicine or medical device is an improvement. Health technology assessments (HTA) therefore aim to identify their added value, comparing them with other products. The new law therefore aims to boost cooperation between member states in the field of HTA, by laying out the procedure for member states to carry out voluntary joint assessments. Provisions cover aspects such as rules for sharing data, setting up coordination groups, avoiding conflicts of interest among experts, and publishing the results of the joint work.

 HTAs are under the exclusive competence of Member States. However, multiple countries carrying out parallel assessments, under diverging national laws, may result in a duplication of requests and increase the financial and administrative burden on health technology developers, say MEPs.

This burden acts as a barrier to the free movement of health technologies and the smooth functioning of the internal market, and delays patients’ access to innovative treatments.

Similar articles

  • MEPs move to tighten rules on London-based investment banks

    MEPs move to tighten rules on London-based investment banks

    A committee of EU lawmakers on Monday backed new rules to prevent large London-based investment banks from carrying out key activities in the EU after Brexit, unless they set up fully-fledged branches in the bloc. The new rules, if approved by EU states and by the whole European Parliament in a second vote, would force foreign investment banks to set up branches in the Eurozone if they want to perform services such as proprietary trading and underwriting of bonds and other securities in the bloc.

  • Tech giants to pay authors of films, music, news they use

    Tech giants to pay authors of films, music, news they use

    After complicated discussions, lawmakers moved forward on the copyright reform and finally succeeded to agree on 12 September in the plenary in Strasbourg the revised negotiation position of the Parliament. The standpoint for starting talks with the national governments of EU28 was backed by 438 votes to 226, with 39 abstentions.

  • MEPs slash dual quality goods

    MEPs slash dual quality goods

    A product sold under the same brand and packaging should have the same content

    At the plenary session on 13 September in Strasbourg MEPs overwhelmingly backed the non-legislative resolution that firmly opposes the scandalous practice of dual quality products. Over years, consumers from Central and Eastern European countries are buying well-known brands of food - including for babies, as well as cosmetics and detergents, among others, with dubious content and quality, often at very high prices, sometimes even higher than in the Western countries.